Red Cell Indices (Mean Cell Volume(MCV), Mean Cell Haemoglobin(MCH), Mean Cell Haemoglobin Concentration(MCHC), Red Cell Distribution Width(RCDW))

MCV (mean corpuscular volume) measures average red blood cell size, used to classify anemia as microcytic or macrocytic. MCH (mean corpuscular hemoglobin) indicates average hemoglobin amount per red cell, reflecting cell hemoglobin content. MCHC (mean corpuscular hemoglobin concentration) shows average hemoglobin concentration within red cells, useful for identifying hypochromic or normochromic anemia. Abnormal values guide further testing and treatment.

Red blood cell indices are lab measures that assess red cell size, hemoglobin content, and distribution. Key values: RBC count, hemoglobin (oxygen-carrying protein), hematocrit (percentage of blood that’s red cells), MCV (mean cell volume), MCH (mean corpuscular hemoglobin), MCHC (concentration), and RDW (size variation). Abnormal patterns help diagnose anemia types and guide further testing.

MCV (mean corpuscular volume) — the average size of a red blood cell, measured in femtoliters. MCH (mean corpuscular hemoglobin) — the average amount of hemoglobin per red cell, measured in picograms. MCHC (mean corpuscular hemoglobin concentration) — the average hemoglobin concentration in packed red cells, measured in g/dL. RDW (red cell distribution width) — the percent variation in red blood cell size.

MCV (mean corpuscular volume) is a red-cell index measuring the average volume of a single red blood cell, reported in femtoliters (fL). It’s calculated from hematocrit and RBC count (MCV = [Hct (%) × 10] ÷ RBC [million/µL]). Normal values are about 80–100 fL. Low MCV suggests microcytic causes (iron deficiency, thalassemia); high MCV indicates macrocytic causes (B12/folate deficiency, alcohol).

High MCV (macrocytosis) can be seen with hematologic cancers—myelodysplastic syndromes, acute and chronic leukemias, and some lymphomas—or when bone marrow is infiltrated by metastatic solid tumours. Solid cancers causing B12/folate malabsorption (gastric, pancreatic, small-bowel) can also produce macrocytosis. Chemotherapy and marrow-toxic cancer treatments commonly raise MCV as well. Evaluation should include B12/folate, liver tests, and bone marrow assessment when cancer is suspected.

Thalassemia is an inherited blood disorder causing reduced hemoglobin production due to mutations affecting alpha or beta globin chains. It causes varying anemia severity, fatigue, pallor, growth delay and bone changes; severe forms require regular blood transfusions and iron‑chelation therapy. Diagnosis uses blood counts, hemoglobin electrophoresis and genetic testing. Management includes transfusions, chelation, folic acid and occasionally stem‑cell transplant.